Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-16-104922
Filing Date
2016-03-14
Accepted
2016-03-14 16:21:45
Documents
80
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a15-23369_110k.htm 10-K 1903412
2 EX-21.1 a15-23369_1ex21d1.htm EX-21.1 1571
3 EX-23.1 a15-23369_1ex23d1.htm EX-23.1 5683
4 EX-31.1 a15-23369_1ex31d1.htm EX-31.1 10426
5 EX-31.2 a15-23369_1ex31d2.htm EX-31.2 10270
6 EX-32.1 a15-23369_1ex32d1.htm EX-32.1 5184
7 EX-32.2 a15-23369_1ex32d2.htm EX-32.2 5176
14 GRAPHIC g233691bsi001.gif GRAPHIC 25705
  Complete submission text file 0001104659-16-104922.txt   7742788

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT stml-20151231.xml EX-101.INS 1785644
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20151231.xsd EX-101.SCH 50363
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20151231_cal.xml EX-101.CAL 52021
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20151231_def.xml EX-101.DEF 165257
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20151231_lab.xml EX-101.LAB 534604
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20151231_pre.xml EX-101.PRE 358088
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

EIN.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35619 | Film No.: 161504099
SIC: 2834 Pharmaceutical Preparations